Phase II Study to Assess the Safety, Imaging, Pharmacodynamic and Clinical Outcomes of Acute Ischemic Stroke Subjects Treated With tPA and THR-18

Trial Profile

Phase II Study to Assess the Safety, Imaging, Pharmacodynamic and Clinical Outcomes of Acute Ischemic Stroke Subjects Treated With tPA and THR-18

Recruiting
Phase of Trial: Phase II

Latest Information Update: 23 Nov 2015

At a glance

  • Drugs THR 18 (Primary)
  • Indications Stroke
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors D-Pharm
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 16 Nov 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
    • 14 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top